Molecular basis of partial lipodystrophy and prospects for therapy

Trends in Molecular Medicine

Volumn 7, Issue 3, 2001, Pages 121-126

  Hegele, Robert A ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIN A; LAMIN C; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THIAZOLIDINE DERIVATIVE; TROGLITAZONE;

ADIPOSE TISSUE; CELL NUCLEUS MEMBRANE; CLINICAL FEATURE; DIABETES MELLITUS; GENE MUTATION; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPODYSTROPHY; LIVER TOXICITY; OBESITY; PROTEIN EXPRESSION; REVIEW;

ENDOPEPTIDASES; HUMANS; LAMINS; LIPODYSTROPHY; MUTATION; NUCLEAR PROTEINS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SYNDROME; THIAZOLES;

EID: 0035090666     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(01)01930-X     Document Type: Review

References (47)

1. Pathophysiology of insulin resistance in human disease
2. Insulin resistance and human disease: A short history
3. Lipodystrophy and hepatomegaly with diabetes, lipaemia, and other metabolic disturbances: A case throwing new light on the action of insulin
4. A new genetic variety of lipodystrophy
5. Familial lipoatrophic diabetes with dominant transmission: A new syndrome
6. Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipoatrophic diabetes
7. Familial partial lipodystrophy: Two types of an X-linked dominant syndrome, lethal in the hemizygous state
8. Partial lipoatrophy with insulin resistant diabetes and hyperlipidaemia (Dunnigan syndrome)
9. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety)
10. Localization of the gene for familial partial lipodystrophy (Dunnigan variety) to chromosome 1q21-22
11. A defect in the regional deposition of adipose tissue (partial lipodystrophy) is encoded by a gene at chromosome 1q
12. Confirmation of linkage of hereditary partial lipodystrophy to chromosome 1q21-22
13. Human aryl hydrocarbon receptor nuclear translocator gene (ARNT) D/N511 polymorphism
14. Human C-reactive protein (CRP) 1059G/C polymorphism
15. Nuclear lamins: Their structure, assembly and interactions
16. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy
17. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease
18. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B)
19. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy
20. Lamin A/C mutation in a woman and her two daughters with Dunnigan-type partial lipodystrophy
21. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy
22. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C
23. Heterogeneity of nuclear lamin A mutations in Dunnigan-type familial partial lipodystrophy
24. Lamin A/C: Sex-determined expression in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy
25. cDNA sequencing of nuclear lamins A and C reveals primary and secondary structural homology to intermediate filament proteins
26. Heart to heart: From nuclear proteins to Emery-Dreifuss muscular dystrophy
27. The envelope, please: Nuclear lamins and disease
28. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
29. Pushing the envelope on lipodystrophy
30. Identification of a novel retinoic acid-responsive element within the lamin A/C promoter
31. Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension and diabetes
32. LMNA R482Q mutation in partial lipodystrophy associated with reduced plasma leptin concentration
33. Regulation of fatty acid homeostasis in cells: Novel role of leptin
34. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
35. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
36. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
37. Abdominal obesity and its metabolic complications: Implications for the risk of ischaemic heart disease
38. Genetic variation in LMNA modulates plasma leptin and indices of obesity in aboriginal Canadians
39. Stimulation of adipogenesis in fibroblasts by PPAR Υ2, a lipid-activated transcription factor
40. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor Υ
41. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes
42. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
43. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
44. Myocardial infarction in HIV-infected men receiving protease inhibitors
45. Lessons from lipodystrophy: LMNA, encoding lamin A/C, in HIV therapy-associated lipodystrophy
46. Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation
47. Transcriptional regulation of adipogenesis